Quarterly report pursuant to Section 13 or 15(d)

License Revenue (Tables)

v3.22.2.2
License Revenue (Tables)
9 Months Ended
Sep. 30, 2022
Product Revenue  
Schedule of license revenue

Three Months Ended

Nine Months Ended

September 30, 

September 30, 

2022

2021

2022

2021

Pharmbio Korea Inc.

$

$

$

20

$

Jiangsu Nhwa Pharmaceutical Co. Ltd.

Total license revenues

$

$

$

20

$